In this powerful video, Areti, a 26-year-old pharmacist from Athens, shares her personal battle with cancer and the life-threatening challenges posed by antimicrobial resistance (AMR).
Watch the recording of the online event: "Antimicrobial resistance is invisible, I am not", aimed at raising awareness of the impact of antimicrobial resistance (AMR) on people’s lives, keeping the patients at the centre of the discussion.
This executive summary sets out results derived from 2023 antimicrobial resistance (AMR) data, sourced from invasive isolates reported to both the Central Asian and European Surveillance of Antimicrobial Resistance (CAESAR) network and the European Antimicrobial
Resistance Surveillance Network (EARS-Net).
Gavin, 26 years old, is a haemodialysis patient with chronic kidney disease. For him, the resistant infections became worse than the kidney disease itself.
Data published by ECDC in connection with European Antibiotic Awareness Day shows that, despite improvement in some areas, the EU is lapsing in progress towards its 2030 antimicrobial resistance (AMR) targets.
In 2024, all European Union/European Economic Area (EU/EEA) countries reported data for 2023 to the European Antimicrobial Resistance Surveillance Network (EARS-Net).
This guide for the development of a national One Health roadmap on AMR was developed as a reference for the national human health, animal health and food safety, and environment sector authorities in the Western Balkans.
This report describes the results of the 2023 external quality assessment (EQA) exercise for antimicrobial susceptibility testing (AST) by clinical laboratories that participate in the European Antimicrobial Resistance Surveillance Network (EARS-Net).
Two studies published in Eurosurveillance marking European Antibiotic Awareness Day and World AMR Awareness Week raise the alarm about the spread of bacteria resistant to carbapenems in both healthcare and community settings across Europe.
